Klys et al.
447
1
nals, cm–1: 1028.26, 923.09, 700.03. H NMR (200.1 MHz,
CDCl3) δ: 1.58 (s, 3H), 1.68 (s, 3H), 3.54 (s, 3H), 7.29–7.44
(m, 10H). 13C NMR (50.3 MHz, CDCl3) δ: 23.21, 24.96,
53.16, 121.02, 128.17, 128.34, 128.47, 129.26, 130.16,
132.60, 135.59, 160.73. HR-MS (CI, NH3) m/z calcd. for
C18H21N3O3 (M + H)+: 326.1505; found: 326.1482.
53.35, 99.78, 147.40, 188.23, 220.02. MS (CI, NH3) m/z
calcd. for C9H16N3O4 (M + H)+: 230.24; found: 230.1.
Thermolysis procedure
The oxadiazoline (1.5 mmol) in 5 mL of benzene, added
to 5.25 mmol of tert-butyl alcohol, was heated in a sealed
vessel at 110 °C for 24 h. The tube was then opened, and the
solvent and volatile products were evaporated with a rotary
evaporator. The residue was column chromatographed on sil-
ica gel with petroleum ether – ethyl acetate as the eluent.
Some fractions had to be rechromatographed on a 2 mm sil-
ica plate in a Chromatotron apparatus, with the same sol-
vents for elution. Thermolysis of 2d afforded products 6–8.
The carbene dimer was not found.
Fluorenone-O-(1,5-dihydro-2-methoxy-5,5-dimethyl-1,3,4-
oxadiazol-2-yl)oxime (2f)
Pale yellow solid, mp 105 to 106 °C. IR (most intense
peaks, cm–1): 1166.18, 1098.28, 899.09. 1H NMR
(600 MHz, CDCl3) δ: 1.65 (s, 3H), 1.78 (s, 3H), 3.81 (s,
3H), 7.23 (t, J = 7.2 Hz, 1H), 7.36, 7.33 (t, J = 7.2 Hz, 1H),
7.38 (t, J = 7.2 Hz, 1H), 7.45 (t, J = 7.2 Hz, 1H), 7.58 (d,
J = 7.2 Hz, 1H), 7.60 (d, J = 7.2 Hz, 1H), 7.63 (d, J =
7.2 Hz, 1H), 8.33 (d, J = 7.2 Hz, 1H). 13C NMR (150 MHz,
CDCl3) δ: 23.27, 24.94, 53.47, 120.13, 120.17, 121.80,
122.41, 128.17, 128.59, 129.99, 130.35, 130.91, 132.01,
135.00, 138.80, 140.88, 142.13, 155.33. HR-MS (CI, NH3)
m/z calcd. for C18H18N3O3 (M + H)+: 324.1348; found:
324.1331.
Acetophenone-O-(tert-butoxy)(methoxymethylene)oxime
(6)
1
Colourless oil, yield 35%. H NMR (600 MHz, CDCl3) δ:
1.35 (s, 9H), 2.29 (s, 3H), 3.42 (s, 3H), 6.00 (s, 1H), 7.35–
7.36 (m, 3H), 7.65–7.67 (m, 2H). 13C NMR (150 MHz,
CDCl3) δ: 13.48, 14.27, 28.97, 31.74, 51.31, 113.90, 126.42,
128.51, 129.43, 156.07.
2,3,4,5-Tetraphenylcyclopentadienone-O-(1,5-dihydro-2-
methoxy-5,5-dimethyl-1,3,4-oxadiazol-2-yl)oxime (2g)
1
Reddish foam. H NMR (200 MHz, CDCl3) δ: 1.05 (s,
Methyl (phenylethylidene)carbamate (7)
Colourless oil, in 30% yield. H NMR (600 MHz, CDCl3)
δ: 2.39 (s, 3H), 3.92 (s, 3H), 7.39–7.45 (m, 3H), 7.72–7.73
(m, 2H). 13C NMR (150 MHz, CDCl3) δ: 13.88, 54.81,
126.53, 128.12, 130.15, 134.09, 153.99 (C=N), 162.22
(C=O).
1
3H), 1.38 (s, 3H), 3.03 (s, 3H), 6.73–6.85 (m, 4H), 6.99–
7.27 (m, 16H). 13C NMR (50.3 MHz, CDCl3) δ: 21.99,
25.10, 53.30, 121.60, 124.69, 126.75, 126.98, 127.21,
127.47, 127.61, 127.76, 130.01, 130.08, 130.66, 131.32,
132.66, 132.51, 132.66, 133.60, 134.05, 136.30, 138.16,
145.61, 151.57, 160.88. HR-MS (CI, NH3) m/z calcd. for
C34H29N3O3: 527.2209; found: 527.2213.
Acetophenone azine (8) (13)
1
Yield: 7%. H NMR (200.2 MHz, CDCl3) δ: 2.33 (s, 6H),
Cyclopentanone-O-(1,5-dihydro-2-methoxy-5,5-dimethyl-
7.42–7.45 (m, 6H), 7.91–7.93 (m, 4H). 13C NMR (150 MHz,
CDCl3) δ: 15.25, 126.82, 128.51, 129.83, 138.51, 158.15.
HR-MS (CI, NH3) m/z calcd. for C16H16N2: 236.1313;
found: 236.1313 and 237.1387 (M + H)+.
1,3,4-oxadiazol-2-yl)oxime (2h)
1
Colourless oil. H NMR (200 MHz, CDCl3) δ: 1.57 and
1.62 (2s, superimposed on m, total 10H), 2.18 (m, 2H), 2.53
(m, 2H), 3.60 (s, 3H). 13C NMR (150 MHz, CDCl3) δ:
23.19, 24.77, 25.48, 25.70, 25.99, 26.82, 32.18, 52.86,
120.34, 138.46, 164.34. MS (CI, NH3) m/z calcd. for
C5H9N2O2 (M – C5H8NO)+: 129.14; found: 129.1 (100%).
Thermolysis of 2e afforded benzophenone-O-(tert-
butoxy)(methoxymethylene)oxime (9), the carbene dimer
(10), methyl (diphenylmethylene)carbamate (MeOCON=CPh2,
11) (14), and benzophenone azine (12, 5%) (15).
Cyclohexanone-O-(1,5-dihydro-2-methoxy-5,5-dimethyl-
1,3,4-oxadiazol-2-yl)oxime (2i)
Benzophenone-O-(tert-butoxy)(methoxymethylene)oxime
(9)
Colourless oil. IR (C=N and four most intense peaks, cm–1):
1
Compound 9 was very susceptible to hydrolysis and was
not obtained in a pure state. Yield: ca. 32%. 1H NMR
(200.2 MHz, CDCl3) δ: 1.29 (s, 9H), 3.40 (s, 3H), 5.99 (s,
1H), 7.31–7.52 (m, 10H). 13C NMR (50.3 MHz, CDCl3) δ:
28.92, 51.38, 114.01, 128.02–129.58 (eight signals visible in
this range, but not resolved). A meaningful mass spectrum
could not be obtained.
1763.2, 1164.3, 1101.8, 897.8, 862.3. H NMR (600 MHz,
CDCl3) δ: 1.57 (s, 3H), 1.61 (s, 3H), 1.70–1.80 (m, 6H),
2.36 (distorted t, 2H), 2.52 (distorted t, 2H), 3.59 (s, 3H).
13C NMR (150 MHz, CDCl3) δ: 23.33, 24.70, 25.23, 28.43,
31.31, 52.87, 120.49, 125.67, 138.29, 171.14. MS (CI, NH3)
m/z calcd. for C5H9N2O2 (M – C6H10NO)+: 129.14; found:
129.1 (100%).
Biacetyl-O-(1,5-dihydro-2-methoxy-5,5-dimethyl-1,3,4-
oxadiazol-2-yl)]monoxime (2j)
1,2-Dimethoxy-1,2-(diphenyliminoxy)ethene (10)
1
Colourless oil, yield 12%. H NMR (200.2 MHz, CDCl3)
Colourless oil. IR (neat, cm–1): 1702.4 (C=O), 913.3
(most intense fingerprint peak). 1H NMR (200.2 MHz,
CDCl3) δ: 1.59 (s, 3H), 1.67 (s, 3H), 2.05 (s, 3H), 2.28 (s,
δ: 3.66 (s, 6H), 7.33–7.27 (m, 10H). 13C NMR (50.3 MHz,
CDCl3) δ: 55.40, 128.45, 128.55, 129.03, 129.17, 129.94,
131.08, 132.20, 134.70, 154.67, 164.63. A correlation be-
tween the 1H and 13C NMR signals was established by
means of gradient HSQC spectra. The trans isomer was as-
sumed.
1
3H), 3.70 (s, 3H). H NMR (200.2 MHz, C6D6) δ: 1.27 (s,
3H), 1.40 (s, 3H), 1.76 (s, 3H), 1.90 (s, 3H), 3.44 (s, 3H).
13C NMR (50.3 MHz, CDCl3) δ: 9.54, 23.30, 24.81, 25.59,
© 2005 NRC Canada